Tower Research Capital (TRC)’s Genpact G Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $187K | Sell |
5,031
-1,128
| -18% | -$46.5K | ﹤0.01% | 1675 |
|
|
2025
Q4 | $288K | Sell |
6,159
-1,663
| -21% | -$71.9K | 0.01% | 1175 |
|
|
2025
Q3 | $328K | Buy |
7,822
+553
| +8% | +$24.3K | 0.01% | 1133 |
|
|
2025
Q2 | $320K | Sell |
7,269
-517
| -7% | -$23.4K | 0.01% | 1365 |
|
|
2025
Q1 | $392K | Sell |
7,786
-2,000
| -20% | -$99.2K | 0.01% | 980 |
|
|
2024
Q4 | $420K | Buy |
9,786
+7,451
| +319% | +$314K | 0.01% | 1192 |
|
|
2024
Q3 | $91.6K | Sell |
2,335
-5,411
| -70% | -$196K | ﹤0.01% | 2309 |
|
|
2024
Q2 | $249K | Sell |
7,746
-7,390
| -49% | -$238K | ﹤0.01% | 1900 |
|
|
2024
Q1 | $499K | Sell |
15,136
-2,224
| -13% | -$77.3K | 0.01% | 865 |
|
|
2023
Q4 | $603K | Sell |
17,360
-1,079
| -6% | -$37.2K | 0.01% | 1225 |
|
|
2023
Q3 | $667K | Buy |
18,439
+7,189
| +64% | +$267K | 0.02% | 720 |
|
|
2023
Q2 | $423K | Buy |
11,250
+7,495
| +200% | +$302K | 0.01% | 1087 |
|
|
2023
Q1 | $174K | Buy |
3,755
+386
| +11% | +$18K | 0.01% | 1445 |
|
|
2022
Q4 | $156K | Sell |
3,369
-5,351
| -61% | -$243K | 0.01% | 1480 |
|
|
2022
Q3 | $382K | Sell |
8,720
-2,142
| -20% | -$98.5K | 0.01% | 1352 |
|
|
2022
Q2 | $460K | Sell |
10,862
-10,581
| -49% | -$449K | 0.01% | 1193 |
|
|
2022
Q1 | $933K | Buy |
21,443
+8,416
| +65% | +$390K | 0.01% | 817 |
|
|
2021
Q4 | $692K | Sell |
13,027
-414
| -3% | -$20.8K | 0.01% | 908 |
|
|
2021
Q3 | $638K | Sell |
13,441
-695
| -5% | -$34.5K | 0.02% | 820 |
|
|
2021
Q2 | $642K | Buy |
14,136
+1,529
| +12% | +$69.2K | 0.02% | 975 |
|
|
2021
Q1 | $540K | Sell |
12,607
-2,057
| -14% | -$85.4K | 0.01% | 1181 |
|
|
2020
Q4 | $606K | Buy |
14,664
+9,244
| +171% | +$365K | 0.02% | 849 |
|
|
2020
Q3 | $211K | Buy |
+5,420
| New | +$214K | ﹤0.01% | 2529 |
|
|
2020
Q2 | – | Sell |
-6,655
| Closed | -$194K | – | 4824 |
|
|
2020
Q1 | $194K | Buy |
6,655
+4,773
| +254% | +$187K | 0.01% | 764 |
|
|
2019
Q4 | $79K | Buy |
1,882
+792
| +73% | +$31.6K | 0.01% | 1074 |
|
|
2019
Q3 | $43K | Buy |
+1,090
| New | +$43.2K | ﹤0.01% | 1907 |
|
|
2018
Q4 | – | Sell |
-1,908
| Closed | -$58K | – | 3996 |
|
|
2018
Q3 | $58K | Sell |
1,908
-1,114
| -37% | -$33.8K | ﹤0.01% | 1671 |
|
|
2018
Q2 | $88K | Buy |
3,022
+597
| +25% | +$18.5K | ﹤0.01% | 1517 |
|
|
2018
Q1 | $77K | Buy |
2,425
+2,226
| +1,119% | +$72.3K | 0.01% | 1433 |
|
|
2017
Q4 | $6K | Sell |
199
-6,862
| -97% | -$212K | ﹤0.01% | 2811 |
|
|
2017
Q3 | $203K | Sell |
7,061
-2,271
| -24% | -$64.7K | 0.02% | 752 |
|
|
2017
Q2 | $259K | Buy |
9,332
+8,034
| +619% | +$208K | 0.03% | 291 |
|
|
2017
Q1 | $32K | Sell |
1,298
-537
| -29% | -$13.1K | ﹤0.01% | 982 |
|
|
2016
Q4 | $44K | Sell |
1,835
-60
| -3% | -$1.43K | ﹤0.01% | 1504 |
|
|
2016
Q3 | $46K | Buy |
+1,895
| New | +$46.9K | ﹤0.01% | 1193 |
|
|
2016
Q2 | – | Sell |
-1,188
| Closed | -$32K | – | 4611 |
|
|
2016
Q1 | $32K | Buy |
1,188
+627
| +112% | +$15.9K | ﹤0.01% | 1023 |
|
|
2015
Q4 | $14K | Buy |
+561
| New | +$13.9K | ﹤0.01% | 1686 |
|
|
2015
Q3 | – | Sell |
-16
| Closed | – | – | 4265 |
|
|
2015
Q2 | $0 | Buy |
+16
| New | +$358 | ﹤0.01% | 4597 |
|
|
2015
Q1 | – | Sell |
-6,045
| Closed | -$114K | – | 4580 |
|
|
2014
Q4 | $114K | Buy |
6,045
+5,401
| +839% | +$95.1K | 0.01% | 537 |
|
|
2014
Q3 | $11K | Buy |
644
+291
| +82% | +$5.1K | ﹤0.01% | 2752 |
|
|
2014
Q2 | $6K | Sell |
353
-104
| -23% | -$1.78K | ﹤0.01% | 2715 |
|
|
2014
Q1 | $8K | Sell |
457
-6,187
| -93% | -$104K | ﹤0.01% | 2816 |
|
|
2013
Q4 | $122K | Buy |
6,644
+5,903
| +797% | +$110K | 0.02% | 747 |
|
|
2013
Q3 | $14K | Sell |
741
-6,507
| -90% | -$130K | ﹤0.01% | 2954 |
|
|
2013
Q2 | $140K | Buy |
+7,248
| New | +$138K | 0.01% | 364 |
|
Other funds holding G
NIEF
VPM
VCM
Tower Research Capital (TRC)'s G Position: Q1 2026 in Review
Tower Research Capital (TRC) reduced its Genpact (G) stake by 18% in Q1 2026, selling an estimated $46.5K and leaving 5,031 shares worth $187K. The position accounts for ﹤0.01% of the portfolio, ranked #1675.
Tower Research Capital (TRC) first reported a position in G in Q2 2013 and has held it in 45 quarters since. The position peaked at $933K in Q1 2022. 515 funds tracked by Wall St. Rank hold G as of Q1 2026.
- Tower Research Capital (TRC) held 5,031 shares of Genpact worth $187K as of Q1 2026.
- Tower Research Capital (TRC) sold 1,128 Genpact shares in Q1 2026, an estimated $46.5K.
- Genpact made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #1675 holding.
- Tower Research Capital (TRC) first reported a position in Genpact in Q2 2013 and has held it in 45 quarters since.
- Tower Research Capital (TRC)'s Genpact position peaked at $933K in Q1 2022.
- 515 funds tracked by Wall St. Rank held Genpact as of Q1 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.